Evidence map›Paper›PMID 40813534›Full record

ArticleRadiological physics and technology2025

Automatic segmentation of cone beam CT images using treatment planning CT images in patients with prostate cancer.

Yoshiki Takayama, Noriyuki Kadoya, Takaya Yamamoto, Yuya Miyasaka, Yosuke Kusano, Tomohiro Kajikawa, Seiji Tomori, Yoshiyuki Katsuta, Shohei Tanaka, Kazuhiro Arai and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yoshiki TakayamaDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Noriyuki KadoyaDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan. noriyuki.kadoya.e4@tohoku.ac.jp.ORCID http://orcid.org/0000-0001-5018-3800
Takaya YamamotoDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Yuya MiyasakaDepartment of Heavy Particle Medical Science, Yamagata University Faculty of Medicine, 2-2-2 Iida-Nishi, Yamagata, 990-9585, Japan.
Yosuke KusanoSection of Medical Physics and Engineering, Kanagawa Cancer Center, 2-3-2 Nakao, Asahi, Yokohama, Kanagawa, 241-8515, Japan.
Tomohiro KajikawaDepartment of Radiology, Kyoto Prefectural University of Medicine, 465 Kajiicho, Kawaramachi Hirokoji, Kamigyo, Kyoto, 602-8566, Japan.
Seiji TomoriDepartment of Radiology, National Hospital Organization Sendai Medical Center, Miyagino 2-11-12, Sendai, Miyagi, 983-8520, Japan.
Yoshiyuki KatsutaDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Shohei TanakaDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Kazuhiro AraiDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Ken TakedaDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.
Keiichi JinguDepartment of Radiation Oncology, Tohoku University Graduate School of Medicine, 1-1 Seiryo-machi, Aoba-ku, Sendai, Miyagi, 980-8574, Japan.

Funding

Toshiba Energy Systems and Solutions Corporation 2019-Epi-102
6 · The paper itself

Abstract

Cone-beam computed tomography-based online adaptive radiotherapy (CBCT-based online ART) is currently used in clinical practice; however, deep learning-based segmentation of CBCT images remains challenging. Previous studies generated CBCT datasets for segmentation by adding contours outside clinical practice or synthesizing tissue contrast-enhanced diagnostic images paired with CBCT images. This study aimed to improve CBCT segmentation by matching the treatment planning CT (tpCT) image quality to CBCT images without altering the tpCT image or its contours. A deep-learning-based CBCT segmentation model was trained for the male pelvis using only the tpCT dataset. To bridge the quality gap between tpCT and routine CBCT images, an artificial pseudo-CBCT dataset was generated using Gaussian noise and Fourier domain adaptation (FDA) for 80 tpCT datasets (the hybrid FDA method). A five-fold cross-validation approach was used for model training. For comparison, atlas-based segmentation was performed with a registered tpCT dataset. The Dice similarity coefficient (DSC) assessed contour quality between the model-predicted and reference manual contours. The average DSC values for the clinical target volume, bladder, and rectum using the hybrid FDA method were 0.71 ± 0.08, 0.84 ± 0.08, and 0.78 ± 0.06, respectively. Conversely, the values for the model using plain tpCT were 0.40 ± 0.12, 0.17 ± 0.21, and 0.18 ± 0.14, and for the atlas-based model were 0.66 ± 0.13, 0.59 ± 0.16, and 0.66 ± 0.11, respectively. The segmentation model using the hybrid FDA method demonstrated significantly higher accuracy than models trained on plain tpCT datasets and those using atlas-based segmentation.

Indexed as

Cone-Beam Computed TomographyImage Processing, Computer-AssistedProstatic NeoplasmsRadiotherapy Planning, Computer-AssistedAutomationDeep LearningHumansMaleCone beam CTDeep learning-based automatic segmentationFourier domain adaptationMale pelvic regionTreatment planning CTUnsupervised domain adaptation

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.